All are true regarding retinoblastoma except:
**Core Concept**
Retinoblastoma is a malignant tumor of the retina, primarily affecting children. It arises from the retinal stem cells, which are precursors to the retinal photoreceptors. This cancer is characterized by the presence of mutations in the RB1 gene, which encodes the retinoblastoma protein (pRb), a critical regulator of cell cycle progression.
**Why the Correct Answer is Right**
Retinoblastoma is a cancer that can manifest in various ways, including leukocoria (white pupillary reflex), strabismus, and vision loss. The tumor can grow in the retina and may spread to the optic nerve, central nervous system, or other parts of the body. The presence of the RB1 mutation is crucial for the development of retinoblastoma, as it leads to the loss of pRb's ability to regulate the cell cycle, resulting in uncontrolled cell proliferation.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because retinoblastoma is not typically associated with a family history of breast cancer. While there is a link between retinoblastoma and certain types of sarcomas, the connection to breast cancer is not a characteristic feature of this tumor.
**Option B:** This option is incorrect as retinoblastoma does not primarily arise from the choroid. While choroidal melanomas are a type of uveal cancer, they are distinct from retinoblastoma, which originates from the retina.
**Option C:** This option is incorrect as retinoblastoma is not typically associated with a history of radiation exposure. While ionizing radiation can increase the risk of developing certain types of cancer, it is not a primary risk factor for retinoblastoma.
**Clinical Pearl / High-Yield Fact**
Retinoblastoma is a cancer that requires prompt diagnosis and treatment to preserve vision and prevent metastasis. The presence of leukocoria or strabismus in a child should prompt a thorough ophthalmologic examination to rule out retinoblastoma.
**Correct Answer: None. All the options given are true regarding retinoblastoma.**